CDKN2A and breast carcinoma: In addition, CDKN2A was found to be a commonly mutated gene in brain metastases from lung adenocarcinoma25, and a higher prevalence of CDKN2A/p16 has also been observed in the lymph nodes of patients with breast cancer who developed brain metastases26.